Literature DB >> 17641901

Expression pattern and cellular sources of chemokines in primary central nervous system lymphoma.

Anna Brunn1, Manuel Montesinos-Rongen, Andreas Strack, Guido Reifenberger, Christian Mawrin, Carlo Schaller, Martina Deckert.   

Abstract

The expression pattern of a subset of chemokines and their corresponding receptors was investigated in primary central nervous system lymphomas (PCNSL). The tumor cells consistently expressed CXCR4, CXCL12, CXCR5, and CXCL13, both at mRNA and protein levels. Cerebral endothelial cells were positive for CXCL12 and CXCL13, while reactive astrocytes and microglial cells expressed CXCL12, CCR5, and CCR6. Inflammatory T cells in PCNSL were characterized by CCR5 and CCR6 positivity. Taken together, our data indicate a cell type-specific repertoire of chemokine and chemokine receptor expression in PCNSL suggesting that chemokine-mediated interactions facilitate crossing of the blood-brain barrier as well as intracerebral dissemination of PCNSL cells. In addition, chemokines expressed by tumor cells may contribute to induction of reactive glial changes and influence the composition of inflammatory infiltrates in PCNSL. Therefore, cell type specific expression of distinct chemokine profiles likely plays a role in the pathogenesis of PCNSL and may contribute to their characteristic histological appearance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17641901     DOI: 10.1007/s00401-007-0258-x

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  23 in total

Review 1.  Pathophysiology of retinal lymphoma.

Authors:  Sarah E Coupland; Chi Chao Chan; Justine Smith
Journal:  Ocul Immunol Inflamm       Date:  2009 Jul-Aug       Impact factor: 3.070

2.  Prognostic impact of MYC protein expression in central nervous system diffuse large B-cell lymphoma: comparison with MYC rearrangement and MYC mRNA expression.

Authors:  Seung-Myoung Son; Sang-Yun Ha; Hae-Yong Yoo; Dongryul Oh; Seok-Jin Kim; Won-Seog Kim; Young-Hyeh Ko
Journal:  Mod Pathol       Date:  2016-09-30       Impact factor: 7.842

Review 3.  Characteristics and critical function of CD8+ T cells in the Toxoplasma-infected brain.

Authors:  Tyler A Landrith; Tajie H Harris; Emma H Wilson
Journal:  Semin Immunopathol       Date:  2015-04-22       Impact factor: 9.623

4.  Targeting CXCL13 During Neuroinflammation.

Authors:  Amanda K Huber; David N Irani
Journal:  Adv Neuroimmune Biol       Date:  2015-11-13

5.  Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma risk.

Authors:  Shehnaz K Hussain; Weiming Zhu; Shen-Chih Chang; Elizabeth Crabb Breen; Elena Vendrame; Larry Magpantay; Dan Widney; Daniel Conn; Mary Sehl; Lisa P Jacobson; Jay H Bream; Steven Wolinsky; Charles R Rinaldo; Richard F Ambinder; Roger Detels; Zuo-Feng Zhang; Otoniel Martínez-Maza
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-12-18       Impact factor: 4.254

6.  Prognostic significance of the aggregative perivascular growth pattern of tumor cells in primary central nervous system diffuse large B-cell lymphoma.

Authors:  Miaoxia He; Changjing Zuo; Jianjun Wang; Jianmin Liu; Binghua Jiao; Jianmin Zheng; Zailong Cai
Journal:  Neuro Oncol       Date:  2013-03-12       Impact factor: 12.300

7.  CXCL13 Signaling in the Tumor Microenvironment.

Authors:  Muzammal Hussain; Jinsong Liu; Gui-Zhen Wang; Guang-Biao Zhou
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric origin.

Authors:  Susann Stollberg; Daniel Kämmerer; Elisa Neubauer; Stefan Schulz; Ingrid Simonitsch-Klupp; Barbara Kiesewetter; Markus Raderer; Amelie Lupp
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-20       Impact factor: 4.553

9.  LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.

Authors:  Amanda E D Van Swearingen; Marni B Siegel; Allison M Deal; Maria J Sambade; Alan Hoyle; D Neil Hayes; Heejoon Jo; Paul Little; Elizabeth Claire Dees; Hyman Muss; Trevor Jolly; Timothy M Zagar; Nirali Patel; C Ryan Miller; Joel S Parker; J Keith Smith; Julie Fisher; Nikita Shah; Lisle Nabell; Rita Nanda; Patrick Dillon; Vandana Abramson; Lisa A Carey; Carey K Anders
Journal:  Breast Cancer Res Treat       Date:  2018-06-25       Impact factor: 4.872

Review 10.  Liquid Biomarkers for Improved Diagnosis and Classification of CNS Tumors.

Authors:  Severa Bunda; Jeffrey A Zuccato; Mathew R Voisin; Justin Z Wang; Farshad Nassiri; Vikas Patil; Sheila Mansouri; Gelareh Zadeh
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.